Management of the Two-Week Wait Pathway for Skin Cancer Patients, before and during the Pandemic: Is Virtual Consultation an Option?
Maria-Roxana ChiruSandip HindochaEkaterina BurovaGabriel Cristian BejanLaura-Maria ManeaLiviu-Nicolae GhilenceaPublished in: Journal of personalized medicine (2022)
The equivalent outcomes in the management of skin cancers (SCC, MM) via the two-week pathway through virtual consultations and face-to-face appointments underline the role of telemedicine as a reliable alternative to face-to-face assessments.
Keyphrases
- skin cancer
- end stage renal disease
- ejection fraction
- sars cov
- newly diagnosed
- chronic kidney disease
- coronavirus disease
- prognostic factors
- peritoneal dialysis
- clinical trial
- randomized controlled trial
- primary care
- type diabetes
- metabolic syndrome
- patient reported outcomes
- adipose tissue
- placebo controlled
- general practice
- study protocol
- weight loss
- patient reported
- double blind